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Congenital Heart Disease
How Did We Get Here and Now What?*Roberta G. Williams, MDN o one should be surprised that, overthe past 3 decades, remarkable gains havebeen made in the survival of patients with
congenital heart disease (CHD) because the ﬁeld of
cardiology has been responding to the emergence of
increasing numbers of adult patients with complex
heart disease. Many of us have been in the trenches
as new surgical techniques were developed andwidely
adopted, perioperative care became increasingly
reﬁned, and prenatal diagnosis became available.
Because these innovations have been lesion-speciﬁc,
the surviving population looks different in each
decade. Examining the coincidental timing of these
demographic and environmental changes can be
helpful in planning future resource requirements.SEE PAGE 37The paper by Chamberlain et al. (1) in this issue of
the Journal is a step in that direction. It provides
information on trends in inpatient health care
resource utilization for pediatric patients with CHD
over a 28-year period. The authors performed a
retrospective, epidemiological analysis of the Cali-
fornia Ofﬁce of Statewide Health Planning and
Development database from 1983 to 2011 and identi-
ﬁed regional pediatric cardiology specialty care
centers by California’s Title V program. Increasing
regionalization of surgical discharges was demon-
strated, with discharges from specialty centers
increasing from 61% in 1983 to 96% in 2011.*Editorials published in the Journal of the American College of Cardiology
reﬂect the views of the authors and do not necessarily represent the
views of JACC or the American College of Cardiology.
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lationships relevant to the contents of this paper to disclose.Nonsurgical admissions of patients with complex CHD
were less well regionalized, with 71% of discharges
from specialty centers in 2011. During the study
period, the death rate declined from 51 to 23 deaths
per 100,000 total population of children, making a
strong case for a causal relationship between the
development of highly specialized resources and
surgical survival for the most complex cases of CHD.
As evidence of the increasing complexity of CHD in
the population, the number of discharges increased
only a little more than 5% between 1983 and 2011, but
the total bed-days nearly doubled from 35,753 to
71,278, and the median length of stay for both surgical
and nonsurgical discharges increased by 1 day. These
ﬁndings make the gains in survival even more
impressive but also suggest a sobering cost impact.
Chang and Klitzner (2) studied CHD surgical dis-
charges in California from 1995 to 1997 and calculated
that theoretical regionalization would result in
reduction of surgical mortality from 5.34% to 4.08%,
which is, in fact, exactly the overall surgical and
medical discharge mortality rate shown in the study
by Chamberlain et al. (1). Other studies have found a
substantial reduction in risk-adjusted mortality at
high-volume CHD centers, supporting the concept
of regionalization (3–5). Gurvitz et al. (6) examined
California’s CHD admissions from 2000 to 2002 and
found that care at a regional center expanded from
70% in 12 hospitals in adolescence to 44.8% in
25 hospitals during adulthood, coinciding with a
doubling of emergency admissions. The culmination
of these studies is that regionalization of pediatric
CHD services in California did indeed result in
improved survival of patients with increasingly
complex CHD and that this advantage is degraded
with transition to adult care.
During the span of the study by Chamberlain et al.
(1), discharges of Hispanic patients doubled (from
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4624% to 48%) and discharges of non-Hispanic white
patients dropped by one-half. It will be interesting to
explore the root causes for this demographic shift.
California underwent a substantial population growth
during this time (7), from 25.4 million in 1983 to
37.3 million in 2010. The Hispanic population grew in
absolute size and proportion, and in 2010 represented
38.4% of the population. In addition, access to care
improved when, in 1988 and 1990, Medi-Cal (the state
Medicaid program) expanded coverage of pregnant
women and children. The dramatic increase in
admissions of Hispanic patients may be the result
of multiple factors such as immigration, access to
prenatal services, and religious views against termi-
nation of pregnancy. Although the proportion of non-
Hispanic white subjects in the state population
decreased from w65% in 1983 to 39.7% in 2011, the
absolute number dropped only slightly (8), impli-
cating other factors such as declining pregnancy rates
or pregnancy termination.
A recent study (9) of adolescents and young adults
with CHD in California found that hospitalization
costs and length of stay decreased in young adult-
hood as the proportion of admissions shifted to more
medical-based and fewer surgical admissions, sug-
gesting that the natural history of CHD is an impor-
tant driver of resource utilization over the lifespan.
Because each decade has brought innovations that
have increased survival of the marginally viable, it is
likely that the pattern of health service utilization will
be different when today’s child with CHD becomes
an adult. It is also noteworthy that the percentage
of pediatric patients covered by public funding
increased from 50% to 66% during this study (1),
which puts some ﬁnancial pressure on high-resource
programs that must provide costly services and
highlights the vulnerability of these programs to
changes in Title V funding.It would be shortsighted to ignore the fact that
health care resources are increasingly constrained
and that CHD is only 1 of many conditions experi-
encing increased survival and competing for scarce
resources. Recent cohorts of patients with CHD will
require increasingly more services throughout their
lives, and it would be unconscionable to invest
heavily in the survival of these children and not
provide the resources to maintain their functional
state throughout life. If we are to be good stewards for
this complex and vulnerable CHD population, we
must also strive to ﬁnd the most efﬁcient and low-
cost strategies to provide the best value for the pa-
tient and to society. This goal requires ongoing efforts
to examine management strategies that provide
the best health outcomes over the lifetime and to
continue developing new strategies that simplify care
and its cost. Development of expensive technology
and systems of care brought us to this era of improved
survival (10), but innovation of streamlined care will
be necessary to maintain the health of these more
fragile patients. Considering the projected cost of
these patients in their mid- to late-adult years, any
strategies that can improve health and delay the cost
of organ transplant or implantable devices will create
signiﬁcant value in return on societal investment.
What have we learned? Regionalization of care, ac-
cess to care, and medical developments have made
staggering improvements in survival of the more se-
vere forms of CHD, leading to a sizable population, the
likes of which the world has never seen. This is both a
reason for pride and a burden of responsibility to
provide effective, sustainable care for these patients.
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